Hommel T, Szeimies R-M
Behandlungszentrum Knappschaftskrankenhaus Recklinghausen, Klinik für Dermatologie und Allergologie, Klinikum VEST GmbH, Dorstener Str. 151, 45657, Recklinghausen, Deutschland.
Hautarzt. 2016 Nov;67(11):867-875. doi: 10.1007/s00105-016-3873-4.
Actinic keratosis (AK) is a very common skin diagnosis in office-based dermatology. Due to the demographic changes with increasing numbers of elderly people, the proportion of patients with AK is expected rise. In order to avoid progression into squamous cell carcinoma, early treatment is recommended. Numerous treatment options are currently available for this purpose. In addition to targeted therapies for isolated AK many field-directed treatment modalities are available. However, the treatment option that is finally chosen depends on a variety of factors (e.g., age of the patient, the extent of the clinical findings) and the patient's needs and therefore has to be customized.
光化性角化病(AK)是门诊皮肤科中非常常见的皮肤诊断。由于人口结构变化,老年人数量增加,预计AK患者的比例将会上升。为避免进展为鳞状细胞癌,建议早期治疗。目前有多种治疗选择可供使用。除了针对孤立性AK的靶向治疗外,还有许多区域定向治疗方法。然而,最终选择的治疗方案取决于多种因素(例如患者年龄、临床表现的程度)以及患者的需求,因此必须进行定制。